Internal Medicine, Nephrology · Glendale, WI
NPI
1265406516
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
5650 N Green Bay Ave Ste 210
Glendale, WI, 53209
Phone (414) 431-5971
Groups this clinician bills Medicare through
Medicare paid, 2024
$210K
1,883 services
Medicare patients, 2024
381
Average age 69
Drug cost, 2024
$381K
3,295 prescriptions
Company payments, 2025
$1,105
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamal Amin was code 90960 (esrd related services (not dialysis)), 454 times for 74 patients. In total Kamal Amin billed 1,883 services in 18 codes, and Medicare paid $210K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 454 | 74 | $253.63 | $115K |
| 90970 ESRD Related Services (not dialysis) | Office | 379 | 11 | $6.89 | $2,613 |
| 99232 Hospital E&M - Subsequent | Facility | 352 | 126 | $56.79 | $20K |
| 99214 Office E&M - Established | Office | 280 | 167 | $82.29 | $23K |
| 90935 Hemodialysis | Facility | 79 | 33 | $52.47 | $4,145 |
| 90961 ESRD Related Services (not dialysis) | Office | 68 | 29 | $214.15 | $15K |
| 99222 Hospital E&M - Initial | Facility | 59 | 54 | $90.83 | $5,359 |
| 90966 ESRD Related Services (not dialysis) | Office | 54 | 12 | $212.18 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 29 | $85.83 | $4,549 |
| 99204 Office E&M - New | Office | 28 | 28 | $102.81 | $2,879 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 12 | $11.06 | $166 |
By year: 2022 $360K for 2,322 services; 2023 $253K for 1,882 services; 2024 $210K for 1,883 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kamal Amin prescribed most often to Medicare patients was Amlodipine Besylate, with 346 prescriptions and refills. In total Kamal Amin wrote 3,295 Medicare prescriptions that cost $381K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 346 | 807 | 111 | $2,112 |
| Losartan Potassium Generic | 326 | 801 | 112 | $2,337 |
| Sevelamer Carbonate Generic | 306 | 475 | 86 | $67K |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 243 | 243 | Under 11 | $82K |
| Hydralazine Hcl Generic | 233 | 442 | 62 | $3,533 |
| Prosol Parenteral Amino Acid 20% No.1 | 229 | 229 | Under 11 | $32K |
| Carvedilol Generic | 172 | 370 | 50 | $1,557 |
| Calcitriol Generic | 161 | 296 | 35 | $3,627 |
| Furosemide Generic | 158 | 341 | 45 | $1,094 |
| Clonidine Hcl Generic | 109 | 197 | 24 | $1,506 |
| Lisinopril Generic | 90 | 210 | 30 | $758 |
| Metoprolol Succinate Generic | 72 | 187 | 22 | $966 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 48 | 132 | 24 | $563 |
| Midodrine Hcl Generic | 46 | 88 | 22 | $4,322 |
| Calcium Acetate Generic | 44 | 74 | 13 | $3,196 |
Brand drugs: - claims; generic drugs: 2,692 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamal Amin $1,105 ($1,105 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novartis Pharmaceuticals Corporation with $196.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $196 |
| Travere Therapeutics, Inc. TVTX | 3 | $95.79 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $89.1 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $88.48 |
| Ardelyx, Inc. ARDX | 4 | $80.41 |
| Mallinckrodt Hospital Products Inc. | 3 | $76.77 |
| Amgen Inc. AMGN | 3 | $67.24 |
| Genzyme Corporation SNY | 2 | $50.9 |
| GlaxoSmithKline, LLC. GSK | 3 | $49.89 |
| Fresenius USA Marketing, Inc. | 2 | $44.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.